| 14H- benzo [c] benzo [4,5] thieno [2,3-a] carbazole[ |
1313395-18-4 |
|
| 3-bromodibenzo[b,d]thiophene |
97511-04-1 |
|
| Elafibranor(GFT505) |
923978-27-2 |
|
| 2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid |
851784-82-2 |
|
| SELEXIPAG interMediate |
475086-75-0 |
|
| 2H-Cyclopenta[b]furan-2-one,hexahydro-4-[(1E,3S,5S)-5-Methyl-3-[(tetrahydro-2H-pyran-2-yl)oxy]-1-nonen-1-yl]-5-[(tetrahydro-2H-pyran-2-yl)oxy]-, (3aR,4R,5R,6aS)- |
101849-78-9 |
|
| 7,10-Dimethoxy-10-DAB III |
183133-94-0 |
|
| |
| 4-(2-Methylpropoxy)benzenemethanamine acetate (1:1) |
955997-89-4 |
|
| lenvatinib Mesylate |
857890-39-2 |
|
| Ethyl trans-2-[4-(Boc-aMino)cyclohexyl]acetate |
946598-34-1 |
|
| 4,5-Dihydro-6-oxiMe-iMidazo[4,5,1-jk][1]benzazepine-2,6,7(1H)-trione |
92260-82-7 |
|
| 2-ethynylbenzo[d]oxazole |
40176-79-2 |
|
| 1,2-DICHLOROTETRAMETHYLDISILANE |
4342-61-4 |
|
| O-Methyl-N-nitroisourea |
57538-27-9 |
|
| |
| Encorafenib (LGX818) |
1269440-17-6 |
|
| (N,N-DiMethylaMinoMethyl)styrene |
22826-55-7 |
|
| 2-Butylsulfanyl-thiocarbonylsulfanyl-propionic acid |
480436-46-2 |
|
| IMidazo[1,2-a]pyridine, 8-chloro-6-(trifluoroMethyl)- |
178488-36-3 |
|
| 1-((BENZYLOXY)CARBONYL)PIPERIDIN-4-YL METHANESULFONATE |
199103-19-0 |
|
| |
| |
| 1,3-DIMETHYLPSEUDOURIDINE |
64272-68-0 |
|
| 1-[2-(3,4-Dichlorophenyl)ethyl]-4-Methylpiperazine Dihydrochloride |
206996-13-6 |
|
| methyl 2-(6-aminopyridin-3-yl)acetate |
174891-02-2 |
|
| 6-broMo-3,3-diMethylindolin-2-one |
158326-84-2 |
|
| R 5011 (dopant) |
944537-61-5 |
|
| P005672 hydrochloride |
1035979-44-2 |
|
| 3,3-diMethylbenzo[c][1,2]oxaborol-1(3H)-ol |
221352-10-9 |
|
